Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.34 |
| ▸ | RELA | Q04206 | 2/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.34 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.34 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | HPGDS | O60760 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL5477829 | 1.00 | NOTUM (0.44) | NOTUMALDH1A1NPC1RAB9ASMN1; SMN2 | |
| Biphenyl SCHEMBL28077267 | 0.98 | NOTUM (0.42) | NOTUMALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10618613 | 0.89 | GPR55 (0.40) | NOTUMALDH1A1SMN1; SMN2MAPK1HSD17B10 | |
| Benzene SCHEMBL27338794 | 0.84 | PARP1 (0.33) | — | |
| Biphenyl SCHEMBL28422560 | 0.84 | NOTUM (0.32) | NOTUMALDH1A1 | |
| Naphthalene SCHEMBL27805984 | 0.83 | CYP2A6 (0.40) | ALDH1A1 | |
| Fluorobenzene SCHEMBL28654904 | 0.82 | NFE2L2 (0.32) | — | |
| Iodobenzene SCHEMBL27533418 | 0.82 | HDAC8 (0.33) | — | |
| Phenol SCHEMBL3830856 | 0.82 | CA12 (0.48) | ALDH1A1NPC1RAB9ACYP3A4TDP1 | |
| Benzene SCHEMBL27969752 | 0.82 | PARP1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115260861-B | High-reflection heat-insulation paint and preparation method thereof | 宁波爱甬新材料科技有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-121108070-A | Diphenyl oxadiazole compound or salt thereof, and preparation method and application thereof | 徐州医科大学 | 2025-12-12 | — | — | CN | disclosed |
| CN-115260861-B | High-reflection heat-insulation paint and preparation method thereof | 宁波爱甬新材料科技有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-115260861-A | High-reflection heat-insulation coating and preparation method thereof | 宁波爱甬新材料科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115260861-A | High-reflection heat-insulation coating and preparation method thereof | 宁波爱甬新材料科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-110156761-B | Compound containing coumarin-biphenyl skeleton, preparation method and application thereof | 郑州大学 | 2022-08-09 | — | — | CN | disclosed |
| CN-109956912-B | Carboxylic acid compound containing diphenyl oxadiazole, preparation method and medical application thereof | 中国医学科学院药物研究所 | 2021-10-22 | — | — | CN | disclosed |
| CN-109956912-B | Carboxylic acid compound containing diphenyl oxadiazole, preparation method and medical application thereof | 中国医学科学院药物研究所 | 2021-10-22 | — | — | CN | disclosed |
| CN-109956912-B | Carboxylic acid compound containing diphenyl oxadiazole, preparation method and medical application thereof | 中国医学科学院药物研究所 | 2021-10-22 | — | — | CN | disclosed |
| CN-111103252-A | Structural characterization method of sartan drugs | 上海微谱化工技术服务有限公司 | 2020-05-05 | — | — | CN | disclosed |
| US-6759538-B2 | PREVENTION INFECTIONS OF HEPATITIS C VIRUS | RIGEL PHARMACEUTICALS, INC. | 2004-07-06 | — | — | US | disclosed |
| US-20030165561-A1 | Substituted diphenyl heterocycles useful for treating HCV infection | MIDCAP FINANCIAL TRUST | 2003-09-04 | — | — | US | disclosed |
| WO-2003040112-A1 | SUBSTITUTED DIPHENYL HETEROCYCLES USEFUL FOR TREATING HCV INFECTION | RIGEL PHARMACEUTICALS, INC. (US) | 2003-05-15 | — | — | WO | disclosed |
| US-5338737-A | Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists | WARNER-LAMBERT COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
| US-5338737-A | Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists | WARNER-LAMBERT COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
| US-5338737-A | Biphenyl oxadiazoles and thiadiazoles as angiotensin II antagonists | WARNER-LAMBERT COMPANY (US) | 1994-08-16 | — | — | US | disclosed |
| US-5210204-A | Hypotensive agents and cardiovascular disorders | WARNER-LAMBERT COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5210204-A | Hypotensive agents and cardiovascular disorders | WARNER-LAMBERT COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-5210204-A | Hypotensive agents and cardiovascular disorders | WARNER-LAMBERT COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| US-4975349-A | Bonded to an aromatic hydrocarbon group on an electroconductive substrate | CANON KABUSHIKI KAISHA (JP) | 1990-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165561-A1 | Substituted diphenyl heterocycles useful for treating HCV infection | HAVCR2, HCCS, PCNA | NOTUM 1985/4885ALDH1A1 984/4885NPC1 593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.